• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

270.3101 USD 3.4301 1.29%

As of 20:04:04 ET on 11/25/2014.

Snapshot for Actavis plc (ACT)

Open: 269.3500 Day's Range: 266.5700 - 271.5100 Volume: 3,898,312
Previous Close: 266.8800 52wk Range: 156.4000 - 271.5100 1-Yr Rtn: +66.31%

Stock Chart for ACT

No chart data available.
  • ACT:US 270.3100
  • 1D
  • 1M
  • 1Y
266.8800
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 53.0934
Estimated P/E(12/2014) 19.9050
Relative P/E vs. SPX 2.9043
Earnings Per Share (USD) (ttm) 5.0912
Est. EPS (USD) (12/2014) 13.5800
Est. PEG Ratio 1.0590
Market Cap (M USD) 71,648.67
Shares Outstanding (M) 265.06
30 Day Average Volume 3,542,762
Price/Book (mrq) 2.4572
Price/Sale (ttm) 4.4648
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
R Todd JoyceChief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil